Literature DB >> 34105959

A Reverse Approach to the Total Synthesis of Halichondrin B.

K C Nicolaou1, Saiyong Pan1, Yogesh Shelke1, Dipendu Das1, Qiuji Ye1, Yong Lu1, Susanta Sau1, Ruiyang Bao1, Stephan Rigol1.   

Abstract

A new strategy is described for the total synthesis of halichondrin B featuring reversal of the sequential construction of a number of its cyclic ethers from the classical approach by instead forming C-O bonds first followed by C-C bond formation. Employing the Nicholas reaction to generate linear ethers as precursors for the total synthesis of halichondrin B and other members of the halichondrin and eribulin families of compounds, this novel approach provides new opportunities for the development of improved syntheses of these complex and valuable compounds. In this Article, we report the syntheses of defined fragments I, MN, EFG, and A. Fragments I and MN were then coupled and elaborated to advanced intermediate IJKLMN, which was joined with fragment EFG to afford, after appropriate elaboration and macrolactonization, the more advanced polycyclic intermediate EFGHIJKLMN. Elaboration of the latter and coupling with fragment A followed by further functionalization completed the total synthesis of halichondrin B through a short and convergent pathway.

Entities:  

Year:  2021        PMID: 34105959     DOI: 10.1021/jacs.1c05270

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  2 in total

1.  A unified strategy for the total syntheses of eribulin and a macrolactam analogue of halichondrin B.

Authors:  K C Nicolaou; Saiyong Pan; Yogesh Shelke; Stephan Rigol; Ruiyang Bao; Dipendu Das; Qiuji Ye
Journal:  Proc Natl Acad Sci U S A       Date:  2022-08-05       Impact factor: 12.779

Review 2.  The Tetrahydrofuran Motif in Polyketide Marine Drugs.

Authors:  Laura Fernández-Peña; Carlos Díez-Poza; Paula González-Andrés; Asunción Barbero
Journal:  Mar Drugs       Date:  2022-02-03       Impact factor: 5.118

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.